Global Pharmaceutical Water Market size was valued at USD 23,162.04 million in 2018, grew to USD 41,343.44 million in 2024, and is anticipated to reach USD 88,711.39 million by 2032, expanding at a CAGR of 9.33% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Pharmaceutical Water Market Size 2024
USD 41,343.44 Million
Pharmaceutical Water Market, CAGR
9.33%
Pharmaceutical Water Market Size 2032
USD 88,711.39 Million
The Pharmaceutical Water Market is led by major players such as Ecolab Inc., Veolia Environnement S.A., Thermo Fisher Scientific Inc., SUEZ Water Technologies & Solutions, Danaher Corporation, Evoqua Water Technologies LLC, Kurita Water Industries Ltd., Pall Corporation, ADC Water Management, and Dressler Group GmbH. These companies maintain strong competitive positions through advanced purification technologies, GMP-compliant systems, and strategic global partnerships. Their focus on automation, digital monitoring, and sustainability enhances process reliability and compliance. North America emerged as the leading region in 2024, commanding a 42% market share, supported by a robust pharmaceutical manufacturing base, strict FDA water standards, and ongoing biopharmaceutical expansion.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Global Pharmaceutical Water Market grew from USD 23,162.04 million in 2018 to USD 41,343.44 million in 2024, projected to reach USD 88,711.39 million by 2032 at a CAGR of 9.33%.
Water for Injection (WFI) dominated by 42% share in 2024 due to its critical use in sterile drug and biopharmaceutical manufacturing.
Reverse Osmosis (RO) held the leading position among technologies with a 38% share, driven by efficiency and compliance with pharmacopeia standards.
Pharmaceutical & Biotechnology Manufacturing segment led with 57% share in 2024, supported by expanding vaccine and biologics production.
North America emerged as the leading region with a 42% share, followed by Asia Pacific (32%) and Europe (17%), supported by strong regulatory frameworks and technological advancement.
Market Segment Insights
By Type of Pharmaceutical Water
Water for Injection (WFI) dominated the Pharmaceutical Water Market in 2024 with a 42% share. Its leadership stems from extensive use in sterile drug formulation, parenteral manufacturing, and biopharmaceutical processes requiring ultra-pure water. The segment benefits from strict GMP regulations and rising demand for injectable therapies. Increasing biologics production and advanced purification technologies further boost WFI adoption, reinforcing its dominance across large-scale pharmaceutical and biotechnology facilities worldwide.
For instance, Pfizer expanded its WFI generation capacity at its Kalamazoo, Michigan plant, adding new multi-effect distillation units to support increased sterile injectable output.
By Treatment Technology
Reverse Osmosis (RO) led the Pharmaceutical Water Market in 2024, accounting for a 38% share. The segment’s dominance is driven by its efficiency in removing dissolved solids, microorganisms, and organic impurities at lower operating costs. Growing preference for multi-stage RO systems supports compliance with global pharmacopeia standards. Increasing integration with UV and electrodeionization systems enhances purity levels, making RO the preferred technology for high-capacity water purification in pharmaceutical and biotechnology applications.
For instance, Veolia Water Technologies expanded its Orion product range in 2024 by introducing new RO-EDI systems specifically designed for water-for-injection pre-treatment, ensuring conductivity levels below 1 µS/cm.
By Application
Pharmaceutical & Biotechnology Manufacturing held the largest share of 57% in 2024. The segment growth is fueled by expanding production of vaccines, biosimilars, and sterile injectables requiring consistent water purity. Strict regulatory guidelines and quality assurance protocols promote large-scale adoption of advanced purification systems. Increasing investments in GMP-certified facilities and bioprocessing plants continue to strengthen this segment, as manufacturers prioritize reliable water supply for critical formulation, cleaning, and production processes.
Key Growth Driver
Rising Biopharmaceutical and Injectable Drug Production
Growing demand for biologics, vaccines, and sterile injectables drives the need for high-purity water systems. Pharmaceutical manufacturers increasingly invest in Water for Injection (WFI) and Purified Water technologies to meet stringent quality standards. The expansion of contract manufacturing organizations and advanced bioprocessing facilities further accelerates market growth. Rising global health needs, along with regulatory emphasis on contamination-free production, continue to boost the use of pharmaceutical-grade water in sterile formulation and parenteral drug manufacturing.
For instance, GlaxoSmithKline (GSK) upgraded its high purity water and WFI generation systems at its R&D Biopharmaceutical Pilot Plant in Pennsylvania, installing redundant water systems that provide highly purified water with resistivity greater than 10 Mohm and total organic carbon below 5 ppb, improving reliability and sustainability while reducing yearly operational expenses by approximately $170,000.
Regulatory Compliance and Quality Standards
Strict guidelines from regulatory bodies such as the FDA, EMA, and WHO push pharmaceutical companies to implement validated water purification systems. Adherence to GMP and pharmacopeia standards ensures consistency in product quality and safety. Continuous audits and mandatory testing promote modernization of purification infrastructure. As pharmaceutical firms upgrade facilities to comply with evolving quality norms, the demand for advanced purification technologies such as RO, UV, and distillation systems continues to rise globally.
Technological Advancements in Water Treatment
Innovations in purification technologies enhance efficiency, automation, and sustainability in pharmaceutical water generation. Modern systems combine reverse osmosis, electrodeionization, and UV disinfection to ensure reliable microbial control and reduced operational costs. Smart monitoring and digital control features support predictive maintenance and minimize downtime. These advancements enable pharmaceutical manufacturers to meet strict purity standards while optimizing water recovery, energy efficiency, and system validation, strengthening overall market competitiveness and long-term reliability.
For instance, Veolia’s Orion™ system integrates RO + continuous electrodeionization (CEDI) plus UV, and since 2016 it supports remote digital monitoring via its Hubgrade platform.
Key Trend & Opportunity
Integration of Digital Monitoring and Automation
Automation and digital monitoring are transforming pharmaceutical water management systems. Real-time data analytics and IoT sensors help track conductivity, microbial levels, and system performance. Automated control reduces human error and supports continuous GMP compliance. Companies are adopting cloud-based monitoring platforms to ensure regulatory traceability and operational efficiency. This digital shift not only enhances process validation but also opens opportunities for predictive maintenance and remote quality assurance in pharmaceutical facilities.
For instance, Evoqua Water Technologies deployed its Water One® Cloud service in multiple U.S. pharmaceutical sites, enabling remote monitoring of purified water systems with instant alerts on microbial deviations and conductivity trends.
Sustainability and Water Reuse Initiatives
Pharmaceutical companies increasingly prioritize sustainability by adopting energy-efficient purification and water recovery systems. Technologies such as RO reject recovery, zero-liquid-discharge, and closed-loop reuse minimize environmental impact. Rising environmental regulations and corporate sustainability goals drive investment in eco-friendly purification setups. These initiatives not only lower operational costs but also improve brand credibility, making green purification technologies a key growth opportunity in the pharmaceutical water industry.
For instance, AstraZeneca’s Södertälje site in Sweden piloted Pharem Biotech’s Zymatic bioreactor to remove up to 95 % of organic pollutants in wastewater.
Key Challenge
High Installation and Maintenance Costs
Establishing pharmaceutical-grade water systems involves substantial capital investment in purification units, storage tanks, and validation processes. Continuous maintenance, system monitoring, and regulatory documentation further add to operational expenses. Smaller manufacturers often face budget constraints, limiting their ability to upgrade infrastructure. The high cost of replacement parts, periodic calibration, and energy consumption continues to challenge affordability and scalability, particularly in emerging markets with limited financial and technical resources.
Stringent Validation and Compliance Requirements
The pharmaceutical water industry faces complex validation and documentation obligations under GMP and pharmacopeia standards. Maintaining system qualification and audit readiness demands skilled personnel and continuous monitoring. Failure to comply may result in production delays, recalls, or regulatory penalties. Frequent updates to global standards create additional challenges for companies operating across multiple markets. This compliance burden increases operational complexity and slows system implementation in highly regulated pharmaceutical environments.
Microbial Contamination Risks
Maintaining microbiological purity remains a critical challenge in pharmaceutical water systems. Biofilm formation, stagnant flow zones, and poor maintenance can lead to bacterial growth and endotoxin contamination. Even minor system breaches can compromise entire production batches. Continuous sanitization, real-time monitoring, and design optimization are essential to prevent contamination. Despite advanced purification technologies, ensuring consistent microbial control across distribution loops and storage systems remains a persistent operational and regulatory concern.
Regional Analysis
North America
North America dominated the Pharmaceutical Water Market in 2024 with a 42% share, valued at USD 17,393.16 million, up from USD 9,849.30 million in 2018. The market is projected to reach USD 37,427.29 million by 2032, growing at a CAGR of 9.4%. Strong regulatory frameworks, advanced pharmaceutical manufacturing facilities, and high adoption of Water for Injection (WFI) systems drive regional growth. Continuous investments in biopharmaceutical production and contract manufacturing, along with strict FDA water quality standards, sustain North America’s leadership in global pharmaceutical water demand.
Europe
Europe accounted for a 17% market share in 2024, increasing from USD 4,290.41 million in 2018 to USD 7,235.40 million, and is expected to reach USD 14,105.75 million by 2032 at a CAGR of 8.0%. The region benefits from stringent EMA regulations and growing biologics manufacturing across Germany, France, and the UK. Expansion of GMP-certified production facilities and modernization of purification systems enhance regional market strength. Europe’s focus on quality compliance and sustainable purification technologies supports consistent growth within the global pharmaceutical water landscape.
Asia Pacific
Asia Pacific emerged as the fastest-growing region with a 32% share in 2024, rising from USD 7,116.18 million in 2018 to USD 13,369.21 million, and is forecasted to reach USD 31,138.54 million by 2032 at a CAGR of 10.4%. Rapid industrialization, growing pharmaceutical exports, and increasing biopharmaceutical investments in China, Japan, and India fuel market expansion. Government incentives, rising local drug production, and adoption of advanced water purification systems contribute to its strong growth momentum across manufacturing and research applications.
Latin America
Latin America held a 5% market share in 2024, growing from USD 1,073.44 million in 2018 to USD 1,891.78 million, and is anticipated to reach USD 3,583.74 million by 2032 with a CAGR of 7.6%. The region benefits from expanding pharmaceutical production in Brazil and Argentina, supported by favorable regulatory reforms and foreign investments. Growing demand for purified and sterile water in generics and vaccine manufacturing strengthens market opportunities. Rising healthcare expenditure and modernization of pharmaceutical facilities further support market advancement.
Middle East
The Middle East represented a 3% share of the global market in 2024, increasing from USD 584.48 million in 2018 to USD 943.79 million, and is forecasted to reach USD 1,670.26 million by 2032 at a CAGR of 6.7%. Regional growth is driven by expanding pharmaceutical infrastructure in GCC countries, particularly Saudi Arabia and the UAE. Rising government healthcare investments and partnerships with international drug manufacturers promote adoption of compliant purification systems. The region’s strategic focus on self-sufficiency in pharmaceutical production further enhances long-term growth potential.
Africa
Africa accounted for a 1% market share in 2024, increasing from USD 248.23 million in 2018 to USD 510.10 million, and projected to reach USD 785.81 million by 2032 at a CAGR of 4.8%. Market growth is supported by expanding healthcare access and rising local drug manufacturing, particularly in South Africa and Egypt. Limited infrastructure and high system costs currently restrict large-scale adoption. However, international partnerships and gradual regulatory standardization are expected to drive steady demand for purified water systems in the coming years.
Market Segmentations:
By Type of Pharmaceutical Water
Water for Injection (WFI)
Purified Water
Highly Purified Water
Sterile Water for Injection, Irrigation, Inhalation
Others
By Treatment Technology
Reverse Osmosis (RO)
Ultraviolet (UV) Disinfection
Distillation
Deionization
Others
By Application
Pharmaceutical & Biotechnology Manufacturing
Research Laboratories & Academic Institutes
Contract Manufacturing Organizations (CMOs)
Others
By Region
North America:S., Canada, Mexico
Europe:UK, France, Germany, Italy, Spain, Russia, Rest of Europe
Asia Pacific:China, Japan, South Korea, India, Australia, Southeast Asia, Rest of Asia Pacific
Latin America:Brazil, Argentina, Rest of Latin America
Middle East:GCC Countries, Israel, Turkey, Rest of Middle East
Africa:South Africa, Egypt, Rest of Africa
Competitive Landscape
The Pharmaceutical Water Market features a moderately consolidated competitive landscape dominated by global players such as Ecolab Inc., Veolia Environnement S.A., Thermo Fisher Scientific Inc., SUEZ Water Technologies & Solutions, Danaher Corporation, Evoqua Water Technologies LLC, Kurita Water Industries Ltd., Pall Corporation, ADC Water Management, and Dressler Group GmbH. These companies compete through product innovation, technological integration, and service reliability. They focus on advanced purification technologies, including multi-stage reverse osmosis, UV disinfection, and distillation systems, to meet GMP and pharmacopeia standards. Strategic mergers, acquisitions, and partnerships help them expand regional presence and strengthen compliance-based service portfolios. Increasing investments in digital monitoring, sustainability, and automation enhance operational efficiency and customer value. Additionally, local and regional manufacturers are emerging with cost-effective modular purification systems, intensifying competition. Continuous R&D and customized water solutions tailored for biopharmaceutical, vaccine, and sterile injectable production remain key differentiators driving competitiveness across the global market.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In April 2024, Asahi Kasei launched a new membrane-based system for producing Water for Injection (WFI), designed to replace traditional distillation units and improve energy efficiency.
In February 2024, Veolia Water Technologies introduced its upgraded Polaris 2.0 distillation and steam systems to enhance pharmaceutical WFI generation and reduce operational costs.
In May 2023, Xylem completed the acquisition of Evoqua Water Technologies in a $7.5 billion all-stock deal, expanding its global water treatment capabilities for pharmaceutical applications.
Report Coverage
The research report offers an in-depth analysis based on Type of Pharmaceutical Water, Treatment Technology, Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for high-purity water systems will increase with expanding biologics and vaccine production.
Pharmaceutical manufacturers will adopt automated and digitally monitored purification systems for compliance.
Water for Injection (WFI) systems will see higher adoption due to rising sterile drug production.
Sustainability goals will drive investment in energy-efficient and water-reuse technologies.
Asia Pacific will remain the fastest-growing region due to industrial expansion and local drug manufacturing.
Modular and scalable water purification systems will gain popularity among mid-sized manufacturers.
Partnerships between global purification companies and local pharmaceutical firms will strengthen regional capabilities.
Continuous improvements in reverse osmosis and distillation technologies will enhance operational efficiency.
Regulatory bodies will tighten quality standards, pushing upgrades in validation and documentation processes.
Integration of IoT and AI-based systems will improve predictive maintenance and real-time water quality assurance.
CHAPTER NO. 1: GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2: EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3: PHARMACEUTICAL WATER MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
3.6 Price Trend Analysis
3.6.1 Regional Price Trend
3.6.2 Price Trend by Product CHAPTER NO. 4: KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Application Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Type of Pharmaceutical Water & Application Revenue CHAPTER NO. 6: TRADE & COMMERCE ANALYSIS
6.1. Import Analysis by Region
6.1.1. Global Pharmaceutical Water Import Revenue By Region
6.2. Export Analysis by Region
6.2.1. Global Pharmaceutical Water Export Revenue By Region CHAPTER NO. 7: COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Pharmaceutical Water: Company Market Share
7.2. Global Pharmaceutical Water Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8: PHARMACEUTICAL WATER MARKET – BY TYPE OF PHARMACEUTICAL WATER SEGMENT ANALYSIS
8.1. Pharmaceutical Water Overview by Type of Pharmaceutical Water Segment
8.1.1. Pharmaceutical Water Revenue Share By Type of Pharmaceutical Water
8.2. Water for Injection (WFI)
8.3. Purified Water
8.4. Highly Purified Water
8.5. Sterile Water for Injection, Irrigation, Inhalation
8.6. Others CHAPTER NO. 9: PHARMACEUTICAL WATER MARKET – BY TREATMENT TECHNOLOGY SEGMENT ANALYSIS
9.1. Pharmaceutical Water Overview by Treatment Technology Segment
9.1.1. Pharmaceutical Water Revenue Share By Treatment Technology
9.2. Reverse Osmosis (RO)
9.3. Ultraviolet (UV) Disinfection
9.4. Distillation
9.5. Deionization
9.6. Others CHAPTER NO. 10: PHARMACEUTICAL WATER MARKET – BY APPLICATION SEGMENT ANALYSIS
10.1. Pharmaceutical Water Overview by Application Segment
10.1.1. Pharmaceutical Water Revenue Share By Application
10.2. Pharmaceutical & Biotechnology Manufacturing
10.3. Research Laboratories & Academic Institutes
10.4. Contract Manufacturing Organizations (CMOs)
10.5. Others CHAPTER NO. 11: PHARMACEUTICAL WATER MARKET – REGIONAL ANALYSIS
11.1. Pharmaceutical Water Overview by Region Segment
11.1.1. Global Pharmaceutical Water Revenue Share By Region
11.1.2. Region
11.1.3. Global Pharmaceutical Water Revenue By Region
11.1.4. Type of Pharmaceutical Water
11.1.5. Global Pharmaceutical Water Revenue By Type of Pharmaceutical Water
11.1.6. Treatment Technology
11.1.7. Global Pharmaceutical Water Revenue By Treatment Technology
11.1.8. Application
11.1.9. Global Pharmaceutical Water Revenue By Application CHAPTER NO. 12: NORTH AMERICA PHARMACEUTICAL WATER MARKET – COUNTRY ANALYSIS
12.1. North America Pharmaceutical Water Overview by Country Segment
12.1.1. North America Pharmaceutical Water Revenue Share By Region
12.2. North America
12.2.1. North America Pharmaceutical Water Revenue By Country
12.2.2. Type of Pharmaceutical Water
12.2.3. North America Pharmaceutical Water Revenue By Type of Pharmaceutical Water
12.2.4. Treatment Technology
12.2.5. North America Pharmaceutical Water Revenue By Treatment Technology
12.2.6. Application
12.2.7. North America Pharmaceutical Water Revenue By Application
12.3. U.S.
12.4. Canada
12.5. Mexico CHAPTER NO. 13: EUROPE PHARMACEUTICAL WATER MARKET – COUNTRY ANALYSIS
13.1. Europe Pharmaceutical Water Overview by Country Segment
13.1.1. Europe Pharmaceutical Water Revenue Share By Region
13.2. Europe
13.2.1. Europe Pharmaceutical Water Revenue By Country
13.2.2. Type of Pharmaceutical Water
13.2.3. Europe Pharmaceutical Water Revenue By Type of Pharmaceutical Water
13.2.4. Treatment Technology
13.2.5. Europe Pharmaceutical Water Revenue By Treatment Technology
13.2.6. Application
13.2.7. Europe Pharmaceutical Water Revenue By Application
13.3. UK
13.4. France
13.5. Germany
13.6. Italy
13.7. Spain
13.8. Russia
13.9. Rest of Europe CHAPTER NO. 14: ASIA PACIFIC PHARMACEUTICAL WATER MARKET – COUNTRY ANALYSIS
14.1. Asia Pacific Pharmaceutical Water Overview by Country Segment
14.1.1. Asia Pacific Pharmaceutical Water Revenue Share By Region
14.2. Asia Pacific
14.2.1. Asia Pacific Pharmaceutical Water Revenue By Country
14.2.2. Type of Pharmaceutical Water
14.2.3. Asia Pacific Pharmaceutical Water Revenue By Type of Pharmaceutical Water
14.2.4. Treatment Technology
14.2.5. Asia Pacific Pharmaceutical Water Revenue By Treatment Technology
14.2.5. Application
14.2.7. Asia Pacific Pharmaceutical Water Revenue By Application
14.3. China
14.4. Japan
14.5. South Korea
14.6. India
14.7. Australia
14.8. Southeast Asia
14.9. Rest of Asia Pacific CHAPTER NO. 15: LATIN AMERICA PHARMACEUTICAL WATER MARKET – COUNTRY ANALYSIS
15.1. Latin America Pharmaceutical Water Overview by Country Segment
15.1.1. Latin America Pharmaceutical Water Revenue Share By Region
15.2. Latin America
15.2.1. Latin America Pharmaceutical Water Revenue By Country
15.2.2. Type of Pharmaceutical Water
15.2.3. Latin America Pharmaceutical Water Revenue By Type of Pharmaceutical Water
15.2.4. Treatment Technology
15.2.5. Latin America Pharmaceutical Water Revenue By Treatment Technology
15.2.6. Application
15.2.7. Latin America Pharmaceutical Water Revenue By Application
15.3. Brazil
15.4. Argentina
15.5. Rest of Latin America CHAPTER NO. 16: MIDDLE EAST PHARMACEUTICAL WATER MARKET – COUNTRY ANALYSIS
16.1. Middle East Pharmaceutical Water Overview by Country Segment
16.1.1. Middle East Pharmaceutical Water Revenue Share By Region
16.2. Middle East
16.2.1. Middle East Pharmaceutical Water Revenue By Country
16.2.2. Type of Pharmaceutical Water
16.2.3. Middle East Pharmaceutical Water Revenue By Type of Pharmaceutical Water
16.2.4. Treatment Technology
16.2.5. Middle East Pharmaceutical Water Revenue By Treatment Technology
16.2.6. Application
16.2.7. Middle East Pharmaceutical Water Revenue By Application
16.3. GCC Countries
16.4. Israel
16.5. Turkey
16.6. Rest of Middle East CHAPTER NO. 17: AFRICA PHARMACEUTICAL WATER MARKET – COUNTRY ANALYSIS
17.1. Africa Pharmaceutical Water Overview by Country Segment
17.1.1. Africa Pharmaceutical Water Revenue Share By Region
17.2. Africa
17.2.1. Africa Pharmaceutical Water Revenue By Country
17.2.2. Type of Pharmaceutical Water
17.2.3. Africa Pharmaceutical Water Revenue By Type of Pharmaceutical Water
17.2.4. Treatment Technology
17.2.5. Africa Pharmaceutical Water Revenue By Treatment Technology
17.2.6. Application
17.2.7. Africa Pharmaceutical Water Revenue By Application
17.3. South Africa
17.4. Egypt
17.5. Rest of Africa CHAPTER NO. 18: COMPANY PROFILES
18.1. Ecolab Inc.
18.1.1. Company Overview
18.1.2. Product Portfolio
18.1.3. Financial Overview
18.1.4. Recent Developments
18.1.5. Growth Strategy
18.1.6. SWOT Analysis
18.2. Veolia Environnement S.A.
18.3. Thermo Fisher Scientific Inc.
18.4. Suez Water Technologies & Solutions
18.5. Danaher Corporation
18.6. Evoqua Water Technologies LLC
18.7. Kurita Water Industries Ltd.
18.8. Pall Corporation
18.9. ADC Water Management
18.10. Dressler Group GmbH
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for Pharmaceutical Water Market, and what is its projected size in 2032?
The Pharmaceutical Water Market reached USD 41,343.44 million in 2024 and is projected to reach USD 88,711.39 million by 2032.
At what Compound Annual Growth Rate is the Pharmaceutical Water Market projected to grow between 2025 and 2032?
The Pharmaceutical Water Market is expected to expand at a strong Compound Annual Growth Rate (CAGR) of 9.33% during the forecast period from 2025 to 2032.
Which Pharmaceutical Water Market segment held the largest share in 2024?
The Water for Injection (WFI) segment held the largest share in 2024, accounting for 42% of total revenue due to its extensive pharmaceutical applications.
What are the primary factors fueling the growth of the Pharmaceutical Water Market?
Key growth drivers include increasing biopharmaceutical and vaccine production, stringent regulatory compliance requirements, and rising adoption of advanced purification and digital monitoring technologies.
Who are the leading companies in the Pharmaceutical Water Market?
Major players include Ecolab Inc., Veolia Environnement S.A., Thermo Fisher Scientific Inc., SUEZ Water Technologies, Danaher Corporation, Kurita Water Industries Ltd., and Pall Corporation.
Which region commanded the largest share of the Pharmaceutical Water Market in 2024?
North America dominated the Pharmaceutical Water Market in 2024 with a 42% share, driven by advanced pharmaceutical infrastructure and strict quality compliance standards.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
Australia Pharmaceutical Water Market size was valued at USD 389.54 million in 2018, grew to USD 779.59 million in 2024, and is anticipated to reach USD 1,736.49 million by 2032, expanding at a CAGR of 9.81% during the forecast period.
The Europe Pharmaceutical Water Market was valued at USD 4,290.41 million in 2018, grew to USD 7,235.40 million in 2024, and is anticipated to reach USD 14,105.75 million by 2032, expanding at a CAGR of 8.0% during the forecast period.
The North America Pharmaceutical Water Market was valued at USD 9,849.30 million in 2018, grew to USD 17,393.16 million in 2024, and is projected to reach USD 37,427.29 million by 2032, expanding at a CAGR of 9.4% during the forecast period.
Japan Pharmaceutical Water Market size was valued at USD 819.04 million in 2018, grew to USD 1,672.74 million in 2024, and is anticipated to reach USD 3,843.83 million by 2032, expanding at a CAGR of 10.21% during the forecast period.
The UK Pharmaceutical Water Market was valued at USD 299.29 million in 2018, increased to USD 550.93 million in 2024, and is projected to reach USD 1,087.93 million by 2032, expanding at a CAGR of 8.27% during the forecast period.
The U.S. Pharmaceutical Water Market was valued at USD 5,673.65 million in 2018, increased to USD 11,018.40 million in 2024, and is projected to reach USD 23,471.03 million by 2032, expanding at a CAGR of 9.23% during the forecast period.
The Italy Pharmaceutical Water Market was valued at USD 460.92 million in 2018, grew to USD 817.32 million in 2024, and is projected to reach USD 1,534.50 million by 2032, expanding at a CAGR of 7.63% during the forecast period.
Germany Pharmaceutical Water Market size was valued at USD 658.32 million in 2018 to USD 1,223.46 million in 2024 and is anticipated to reach USD 2,448.13 million by 2032, at a CAGR of 8.44 % during the forecast period.
The France Pharmaceutical Water Market was valued at USD 728.61 million in 2018, grew to USD 1,310.01 million in 2024, and is projected to reach USD 2,505.44 million by 2032, expanding at a CAGR of 7.86% during the forecast period.
The Fabry Disease Therapeutic Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 8.80% between 2024 and 2032. The market was valued at USD 1725.8 million in 2023 and is expected to reach USD 3686.8 million in 2032.
The Foot and Mouth Disease (FMD) Vaccines market size was valued at USD 2.68 billion in 2024 and is projected to reach USD 4.78 billion by 2032, growing at a CAGR of 7.5% during the forecast period.
The Idiopathic Pulmonary Fibrosis (IPF) Treatment market was valued at USD 3.25 billion in 2024 and is projected to reach USD 5.66 billion by 2032, expanding at a CAGR of 7.2% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
